PlexusDx offers flexible commitment tiers so patients can adjust their treatment duration based on progress and clinical guidance from their provider
Last reviewed: May 19, 2026 Last updated: May 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Semaglutide was originally used as a treatment for type 2 diabetes, but after its effects on weight management were observed, it was approved as a treatment for obesity in September 2023
Does Blue Cross Blue Shield Cover Weight Loss Injections
This chain is conjugated to the lysine residue via a carefully calibrated hydrophilic spacer consisting of -Glu and 2-O-Ado molecules
Genazzani AD, Genazzani AR